A federal appeals court upheld the 23-year-old approval of mifepristone, but said a series of actions the FDA took in recent years to make it easier to obtain went too far. Source
A federal appeals court upheld the 23-year-old approval of mifepristone, but said a series of actions the FDA took in recent years to make it easier to obtain went too far. Source